OB polypeptides, modified forms and compositions

• US 6,001,968 A
• Filed: 08/17/1994
• Issued: 12/14/1999
• Est. Priority Date: 08/17/1994
• Status: Expired due to Term

• Current Assignee: Rockefeller University
• Original Assignee: Rockefeller University
• Inventors: Proenca, Ricardo, Friedman, Jeffrey M., Zhang, Yiying
• Primary Examiner(s): Draper, Garnette D.
• Application Number:
  US08/292,345
• Time in Patent Office: 1,945 Days
• Field of Search: 530/350, 530/351, 530/399, 514/2, 514/12, 514/909, 514/910, 424/85.1, 930/120, 930/140
• US Class Current: 530/350
• CPC Class Codes: A01K 2217/05 Animals comprising random inserted nucleic acids (transgenic)
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: A61K 8/64 Proteins; Peptides; Derivatives or degradation products thereof
• CPC Class Codes: A61Q 19/06 for countering cellulitis
• CPC Class Codes: C07K 14/5759 Products of obesity genes, e.g. leptin, obese (OB), tub, fat
• CPC Class Codes: C07K 16/18 against material from animals or humans
• CPC Class Codes: C07K 2319/00 Fusion polypeptide
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers
• CPC Class Codes: C12Q 2600/158 Expression markers
• CPC Class Codes: Y10S 930/12 Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
• CPC Class Codes: Y10S 930/14 Lymphokine; related peptides

Abstract

The present invention relates generally to the control of body weight of animals including mammals and humans, and more particularly to materials identified herein as modulators of body weight, and to diagnostic and therapeutic uses of such modulators. In its broadest aspect, the present invention relates to nucleotide sequences corresponding to the murine and human OB gene, and two isoforms thereof, and proteins expressed by such nucleotides or degenerate variations thereof, that demonstrate the ability co participate in the control of mammalian body weight and that have been postulated to play a critical role in the regulation of body weight and adiposity. The present invention further provides nucleic acid molecules for use as molecular probes or as primers for polymerase chain reaction (PCR) amplification. In further aspects, the present invention provides cloning vectors and mammalian expression vectors comprising the nucleic acid molecules of the invention. The invention further relates to host cells transfected or transformed with an appropriate expression vector and to their use in the preparation of the modulators of the invention. Also provided are antibodies to the OB polypeptide. Moreover, a method for modulating body weight of a mammal is provided.

Claims

1. An isolated mammalian OB polypeptide, said polypeptide having the sequence of a naturally occurring mammalian OB polypeptide, having as a mature protein about 145 amino acids, and capable of modulating body weight.

10. A recombinant OB polypeptide according to any of claims 1-8.

11. A chemically synthesized OB polypeptide according to any of claims 1-8.

12. A pharmaceutical composition for reducing body weight of animal comprising the ob polypeptide of any of claims 1-8 and a pharmaceutically acceptable carrier.

2. An isolated OB polypeptide capable of modulating body weight, the polypeptide comprising:

a) the amino acid sequence set out in SEQ ID NO;

2;

b) the amino acid sequence set out in amino acids 22-167 of SEQ ID NO;

2;

c) the amino acid sequence set out in SEQ ID NO;

4;

or

d) the amino acid sequence set out in amino acids 22-167 of SEQ ID NO;

4.

9. An OB polypeptide according to claim 2 comprising amino acids 22-167 of SEQ ID NO. 4, optionally having an N-terminal methionine, in a pharmaceutically acceptable carrier.

3. An isolated OB polypeptide capable of modulating body weight, the polypeptide comprising:

a) the amino acid sequence set out in amino acids 22-167 of SEQ ID NO;

2 having an N-terminal methionine or an N-terminal polyhistidine;

or

b) the amino acid sequence set out in amino acids 22-167 of SEQ ID NO;

4 having an N-terminal methionine or an N-terminal polyhistidine.

4. An isolated OB polypeptide capable of modulating body weight, the polypeptide comprising:

a) the amino acid sequence set out in SEQ ID NO;

5;

b) the amino acid sequence set out in amino acids 22-166 of SEQ ID NO;

5;

c) the amino acid sequence set out in amino acids 22-166 of SEQ ID NO;

5, having an N-terminal methionine or an N-terminal polyhistidine;

d) the amino acid sequence set out in SEQ ID NO;

6;

e) the amino acid sequence set out in amino acids 22-166 of SEQ ID NO;

6;

or

f) the amino acid sequence set out in amino acids 22-166 of SEQ ID NO;

6 having an N-terminal methionine or an N-terminal polyhistidine.

5. A variant of an OB polypeptide, capable of modulating body weight, comprising amino acids 22-167 of SEQ ID NO:

4 wherein one or more amino acids selected from the group consisting of amino acids 53, 56, 71, 85, 89, 92, 95, 98, 110, 118, 121, 122, 126, 127, 128, 129, 132, 139, 157, 159, 163 and 166 is substituted with a conserved amino acid.

6. A variant of an OB polypeptide, capable of modulating body weighs comprising amino acids 22-167 of SEQ ID NO:

4 wherein one or more amino acids selected from the group consisting of amino acids 53, 56, 71, 85, 89, 92, 95, 98, 110, 121, 122, 126, 127, 128, 129, 139, 157, 159 and 163 is substituted with the particular amino acid present at the corresponding position in SEQ ID NO;

2.

7. A variant of an OB polypeptide, capable of modulating body weight, comprising amino acids 22-166 of SEQ ID NO:

6 wherein one or more of amino acids selected from the group consisting of amino acids 52, 55, 70, 84, 88, 91, 94, 97, 109, 117, 120, 121, 125, 126, 127, 128, 131, 138, 156, 158, 162 and 165 is substituted with a conserved amino acid.

8. A variant of an OB polypeptide, capable of modulating body weight, comprising amino acids 22-166 of SEQ ID NO:

6 wherein one or more of amino acids selected from the group consisting of amino acids 52, 55, 70, 84, 88, 91, 94, 97, 109, 120, 121, 125, 126, 127, 128, 138, 156, 158 and 162 is substituted with the particular amino acid present at the corresponding position in SEQ ID NO;

5.